Haemonetics (NYSE:HAE) reported quarterly earnings of $1.31 per share which beat the analyst consensus estimate of $1.25 by 4.8 percent. This is a 10.08 percent increase over earnings of $1.19 per share from the same period last year. The company reported quarterly sales of $338.967 million which beat the analyst consensus estimate of $331.616 million by 2.22 percent. This is a 2.75 percent decrease over sales of $348.542 million the same period last year.